GR3015782T3 - Escherichia coli vaccine. - Google Patents

Escherichia coli vaccine.

Info

Publication number
GR3015782T3
GR3015782T3 GR950400912T GR950400912T GR3015782T3 GR 3015782 T3 GR3015782 T3 GR 3015782T3 GR 950400912 T GR950400912 T GR 950400912T GR 950400912 T GR950400912 T GR 950400912T GR 3015782 T3 GR3015782 T3 GR 3015782T3
Authority
GR
Greece
Prior art keywords
escherichia coli
coli vaccine
vaccine
escherichia
coli
Prior art date
Application number
GR950400912T
Other languages
Greek (el)
English (en)
Inventor
Den Bosch Johannes Francis Van
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of GR3015782T3 publication Critical patent/GR3015782T3/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/025Enterobacteriales, e.g. Enterobacter
    • A61K39/0258Escherichia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245Escherichia (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GR950400912T 1989-08-18 1995-04-13 Escherichia coli vaccine. GR3015782T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89202110 1989-08-18

Publications (1)

Publication Number Publication Date
GR3015782T3 true GR3015782T3 (en) 1995-07-31

Family

ID=8202455

Family Applications (1)

Application Number Title Priority Date Filing Date
GR950400912T GR3015782T3 (en) 1989-08-18 1995-04-13 Escherichia coli vaccine.

Country Status (16)

Country Link
US (1) US5750115A (enExample)
EP (1) EP0413378B1 (enExample)
JP (1) JP3031561B2 (enExample)
KR (1) KR0177510B1 (enExample)
CN (1) CN1062605C (enExample)
AU (1) AU635062B2 (enExample)
CA (1) CA2022420C (enExample)
DE (1) DE69016129T2 (enExample)
DK (1) DK0413378T3 (enExample)
ES (1) ES2070266T3 (enExample)
GR (1) GR3015782T3 (enExample)
HU (2) HU210965B (enExample)
IL (1) IL95175A (enExample)
NZ (1) NZ234933A (enExample)
TW (1) TW204353B (enExample)
ZA (1) ZA906100B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0314224B1 (en) * 1987-10-26 1992-05-27 Akzo N.V. Vaccine against e.coli septicaemia in poultry
EP1011440A4 (en) * 1997-05-16 2003-08-06 Medical Defense Tech Llc VACCINE AGAINST THE CORE OF LIPOPOLYSACCHARIDES
US6749831B1 (en) * 1997-05-16 2004-06-15 Medical Defense Technology, Llc Vaccine against lipopolysaccharide core
BR9910438A (pt) * 1998-05-15 2001-01-02 Mkb Invest Ltd Partnership Composições e processos para imunização de aves domésticas
US8828226B2 (en) 2003-03-01 2014-09-09 The Trustees Of Boston University System for assessing the efficacy of stored red blood cells using microvascular networks
CN101273133A (zh) * 2005-08-30 2008-09-24 联邦科学工业研究组织 生物活性多肽的细菌传送
EP2355860B1 (en) 2009-10-12 2018-11-21 New Health Sciences, Inc. Blood storage bag system and depletion devices with oxygen and carbon dioxide depletion capabilities
BR112012008682A2 (pt) 2009-10-12 2017-06-20 New Health Sciences Inc "dispositivo de depleção de oxigênio, e, método para remover oxigênio de células vermelhas do sangue."
US11284616B2 (en) 2010-05-05 2022-03-29 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
US9199016B2 (en) 2009-10-12 2015-12-01 New Health Sciences, Inc. System for extended storage of red blood cells and methods of use
US12089589B2 (en) 2009-10-12 2024-09-17 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
EP4091645A1 (en) 2010-08-25 2022-11-23 Hemanext Inc. Method for enhancing red blood cell quality and survival during storage
PT3539381T (pt) 2010-11-05 2023-09-26 Hemanext Inc Irradiação de glóbulos vermelhos e armazenamento anaeróbico
US9067004B2 (en) 2011-03-28 2015-06-30 New Health Sciences, Inc. Method and system for removing oxygen and carbon dioxide during red cell blood processing using an inert carrier gas and manifold assembly
US8926980B2 (en) * 2011-07-11 2015-01-06 Camas Incorporated Compositions against bacterial toxins
ES2742949T3 (es) 2011-08-10 2020-02-17 New Health Sciences Inc Dispositivo integrado de filtrado para el agotamiento de leucocitos, oxígeno y/o co2 y separación de plasma
WO2014134503A1 (en) 2013-02-28 2014-09-04 New Health Sciences, Inc. Gas depletion and gas addition devices for blood treatment
CN107530377B (zh) 2015-03-10 2021-09-03 新健康科学股份有限公司 氧减少一次性套件、装置及其使用方法
CA2983295C (en) 2015-04-23 2024-02-13 New Health Sciences, Inc. Anaerobic blood storage containers
EP3297641B1 (en) 2015-05-18 2025-07-09 Hemanext Inc. Methods for the storage of whole blood, and compositions thereof
PT3463466T (pt) 2016-05-27 2022-04-04 Hemanext Inc Método de armazenamento de sangue anaeróbio e inativação de patógenos
US11260119B2 (en) 2018-08-24 2022-03-01 Pfizer Inc. Escherichia coli compositions and methods thereof
US12138302B2 (en) 2020-10-27 2024-11-12 Pfizer Inc. Escherichia coli compositions and methods thereof
US12357681B2 (en) 2020-12-23 2025-07-15 Pfizer Inc. E. coli FimH mutants and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58135819A (ja) * 1982-02-09 1983-08-12 Nisshin Flour Milling Co Ltd 鶏の大腸菌症の予防法
US4772464A (en) * 1985-08-01 1988-09-20 Miles Laboratories, Inc. Protective antibodies to serotypic determinants of flagellar antigens
US4702911A (en) 1985-09-27 1987-10-27 Immunomed Corporation Preparation of bacterium pili subunits and vaccines containing pili subunits
US4886748A (en) * 1986-03-11 1989-12-12 Shionogi & Co., Ltd. DNA encoding flagellin and vector having the same

Also Published As

Publication number Publication date
DE69016129T2 (de) 1995-05-24
CA2022420C (en) 2000-03-28
US5750115A (en) 1998-05-12
HUT59612A (en) 1992-06-29
DE69016129D1 (de) 1995-03-02
AU635062B2 (en) 1993-03-11
CA2022420A1 (en) 1991-02-19
TW204353B (enExample) 1993-04-21
EP0413378B1 (en) 1995-01-18
ES2070266T3 (es) 1995-06-01
CN1049523A (zh) 1991-02-27
EP0413378A1 (en) 1991-02-20
HU211827A9 (en) 1995-12-28
IL95175A (en) 1994-05-30
IL95175A0 (en) 1991-06-10
AU6109990A (en) 1991-02-21
KR0177510B1 (ko) 1999-03-20
NZ234933A (en) 1992-06-25
DK0413378T3 (da) 1995-05-15
JPH03184996A (ja) 1991-08-12
HU905053D0 (en) 1991-01-28
CN1062605C (zh) 2001-02-28
JP3031561B2 (ja) 2000-04-10
HU210965B (en) 1995-09-28
KR910004209A (ko) 1991-03-28
ZA906100B (en) 1991-05-29

Similar Documents

Publication Publication Date Title
GR3015782T3 (en) Escherichia coli vaccine.
EP0593428A4 (en) MYCONEMATICIDES.
DE69000624D1 (en) Schliessmechanismus.
EP0644419A3 (en) Tracer.
DE69012800D1 (en) Hüftprothese.
EP0641203A4 (en) AMIDAZOLYL-ALCENOIC ACIDS.
OA09205A (en) 3-substituted-2-oxindole derivatives.
ZA927562B (en) Medicament.
DE69001591D1 (en) Tuerschliesser.
DE68907587D1 (en) Trappingssystem.
DE69013161D1 (en) Reibscheibentoroidalgetriebe.
GB2235734B (en) Turbo-rotor construction.
DE59008181D1 (en) Trifluormethylcyclohexan-derivate.
DE59006531D1 (en) Interferometeranordnung.
DE69008186D1 (en) Allylhydroperoxidkettenübertragungsmittel.
ZA904897B (en) Vip-analogs ii.
OA08200A (en) Vaccine.
DE59001720D1 (en) Spruehvorrichtung.
EP0606099A3 (en) Peristaltic pump.
FI891832L (fi) Specialmutant av escherichia coli.
DE59000988D1 (en) Brueckenuntersichtvorrichtung.
AU2432988A (en) Vaccine against e.coli septicaemia in poultry
ZA929294B (en) Syringe.
EP0595970A4 (en) IMPROVED VACCINE.
EP0266401A4 (en) VACCINE.